Shizuoka, Japan

Masaru Otani


Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Shizuoka, JA (1976)
  • Shizuoka, JP (1980 - 1983)

Company Filing History:


Years Active: 1976-1983

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Masaru Otani: Innovator in Antibiotic Development

Introduction

Masaru Otani is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of antibiotics, holding a total of 8 patents. His work has focused on developing new antibiotic compounds that have the potential to combat various bacterial infections.

Latest Patents

Among his latest patents is the antibiotic neplanocin A. This compound is produced by culturing Ampullariella sp. A 11079 FERM-P No. 4494 in a nutrient medium, followed by the separation of neplanocin A from the culture medium. Another significant patent is for the aminoglycoside antibiotic G-367-2, which is believed to have a specific formula. This antibiotic is produced by culturing Dactylosporangium thailandense G-367 FERM-P No. 4840 in a nutrient medium and separating the produced antibiotic. G-367-2 has demonstrated a strong antibacterial effect against Gram-negative bacteria.

Career Highlights

Masaru Otani has worked with prominent companies in the industry, including Toyo Jozo Kabushiki Kaisha and Toyo Jozo Company, Ltd. His experience in these organizations has contributed to his expertise in antibiotic research and development.

Collaborations

Throughout his career, Otani has collaborated with notable colleagues such as Naoki Muto and Shuzo Satoi. These partnerships have likely enhanced his research efforts and led to innovative breakthroughs in antibiotic development.

Conclusion

Masaru Otani's contributions to antibiotic research are significant, with a focus on developing effective treatments against bacterial infections. His patents reflect his dedication to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…